{"id":217,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2022-12-15","marketCap":29132.38671875,"name":"GE Healthcare Technologies Inc","phone":"12033604369.0","outstanding":454.8399963378906,"symbol":"GEHC","website":"https://www.gehealthcare.com","industry":"Health Care"},"price":64.7425,"year":2023,"month":10,"day":21,"weekday":"Saturday","title":"Impact of Interest Rates and Monetary Policy on GE Healthcare Technologies Inc's Stock Price","date":"2023-10-21","url":"/posts/2023/10/21/GEHC","content":[{"section":"Introduction","text":"Interest rates and monetary policy play a significant role in the financial markets, affecting various sectors and companies. This article analyzes their impact on GE Healthcare Technologies Inc's stock price, considering the relationship between interest rates, borrowing costs, and investment decisions."},{"section":"Borrowing Costs","text":"Changes in interest rates can directly impact the borrowing costs for companies like GE Healthcare Technologies Inc. When interest rates rise, borrowing becomes more expensive, as companies need to pay higher interest on their loans. This can lead to increased financial costs for the company, potentially reducing profitability and investor confidence. Conversely, when interest rates fall, borrowing costs decrease, which can lower the financial burden on companies, improve profitability, and increase investor optimism."},{"section":"Investment Decisions","text":"Interest rates also influence investment decisions. When borrowing costs are high due to increased interest rates, companies may postpone or reduce their investment plans. This can limit their capacity to expand, upgrade equipment, or undertake research and development. Consequently, such investment decisions might lower expectations for future growth, potentially decreasing GE Healthcare Technologies Inc's stock price. On the other hand, when interest rates are low, companies are more likely to make investments, as borrowing becomes cheaper. This can stimulate growth, improve market sentiment, and contribute to an increase in the company's stock price."},{"section":"Monetary Policy","text":"Monetary policy decisions by central banks, such as the Federal Reserve, can also impact GE Healthcare Technologies Inc's stock price. Central banks use interest rates as a tool to manage inflation, economic growth, and financial stability. When central banks increase interest rates, it signals a tightening monetary policy aimed at controlling inflation. Higher interest rates may result in reduced consumer spending, economic slowdown, and potential market volatility, which can negatively impact GE Healthcare Technologies Inc's stock price. Conversely, when central banks lower interest rates, it stimulates borrowing and spending, leading to potential market optimism and a positive impact on the company's stock price."},{"section":"Conclusion","text":"In conclusion, changes in interest rates and monetary policy can significantly influence GE Healthcare Technologies Inc's stock price. Rising interest rates increase borrowing costs, potentially affecting profitability and investment decisions. Conversely, falling interest rates can lower borrowing costs, stimulate investment, and improve market sentiment. Additionally, monetary policy decisions by central banks can also impact the company by affecting overall economic conditions and market stability. As an investor in GE Healthcare Technologies Inc, it is crucial to monitor interest rate fluctuations and the subsequent effects on borrowing costs and investment decisions."}],"tags":["stock","Short","Health Care"],"news":[{"category":"company","date":1697809888,"headline":"GE HealthCare: AI-Driven And Undervalued But Timing Not Right","id":123288819,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1480617392/image_1480617392.jpg?io=getty-c-w1536","symbol":"GEHC","publisher":"SeekingAlpha","summary":"General Electric HealthCare was spun off from General Electric and started trading in January this year as an independent healthcare technology. Read more here.","url":"https://seekingalpha.com/article/4642210-ge-healthcare-ai-driven-and-undervalued-but-timing-not-right"},{"category":"company","date":1697716800,"headline":"GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound","id":123253161,"image":"https://media.zenfs.com/en/business-wire.com/970e6f284c128bc71bd34437775a72e4","symbol":"GEHC","publisher":"Yahoo","summary":"CHICAGO, October 19, 2023--GE HealthCare (Nasdaq: GEHC) today announced a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity.","url":"https://finance.yahoo.com/news/ge-healthcare-novo-nordisk-collaborate-120000425.html"},{"category":"company","date":1697710140,"headline":"Big-Name Stock Spinoffs Are Going Mainstream. Here’s Why.","id":123303754,"image":"https://images.barrons.com/im-52332540/social","symbol":"GEHC","publisher":"MarketWatch","summary":"Globalization and easier access to capital are encouraging prominent companies to consider spinoffs, writes Allan Sloan.","url":"https://www.marketwatch.com/articles/stock-spinoffs-kenvue-3m-jnj-3673eeff"},{"category":"company","date":1697704560,"headline":"GE HealthCare teams up with Novo Nordisk to treat diabetes without drugs ","id":123304875,"image":"https://images.mktw.net/im-866288/social","symbol":"GEHC","publisher":"MarketWatch","summary":"New ultrasound technology has potential to regulate metabolic function, early-stage clinical research shows","url":"https://www.marketwatch.com/story/ge-healthcare-teams-up-with-novo-nordisk-to-treat-diabetes-without-drugs-7b679c3e"},{"category":"company","date":1697702760,"headline":"GE HealthCare, Novo Nordisk to advance ultrasound-based obesity therapy","id":123258470,"image":"","symbol":"GEHC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3167993553"},{"category":"company","date":1697701260,"headline":"GE HealthCare teams up with Novo Nordisk to treat diabetes without drugs","id":123258471,"image":"","symbol":"GEHC","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3167962146"},{"category":"company","date":1697699940,"headline":"GE HealthCare, Novo Nordisk team on PFUS to treat type 2 diabetes, no terms","id":123258473,"image":"","symbol":"GEHC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3167938308"},{"category":"company","date":1697544300,"headline":"GE HealthCare to Announce Third Quarter 2023 Results on October 31, 2023","id":123200198,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"GEHC","publisher":"Yahoo","summary":"CHICAGO, October 17, 2023--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its third quarter 2023 financial results before the market opens on Tuesday, October 31, 2023. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast r","url":"https://finance.yahoo.com/news/ge-healthcare-announce-third-quarter-120500204.html"},{"category":"company","date":1697465760,"headline":"GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence","id":123192873,"image":"https://media.zenfs.com/en/business-wire.com/4c221f6a817a0e6cbe1b3050549bc18a","symbol":"GEHC","publisher":"Yahoo","summary":"CHICAGO, October 16, 2023--Today, GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.","url":"https://finance.yahoo.com/news/ge-healthcare-receives-fda-clearance-141600024.html"},{"category":"company","date":1697447880,"headline":"GE HealthCare receives FDA clearance of Allia IGS Pulse","id":123182815,"image":"","symbol":"GEHC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3162564884"},{"category":"company","date":1697436360,"headline":"Expansion of Alzheimer’s Disease Screening Opportunities Bolsters GE Healthcare’s Growth Potential: A Buy Rating Analysis","id":123207666,"image":"","symbol":"GEHC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3163379433"},{"category":"company","date":1697401800,"headline":"GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward","id":123176496,"image":"https://media.zenfs.com/en/business-wire.com/3cef14dfa65eed7d390946258a68be05","symbol":"GEHC","publisher":"Yahoo","summary":"SAN FRANCISCO, October 15, 2023--GE HealthCare (Nasdaq: GEHC) today announced new data from a pilot study conducted with Cleveland Clinic evaluating the Portrait Mobile wireless and wearable monitoring solution. The results demonstrate that continuous patient monitoring with Portrait Mobile resulted in alarm data suitable for optimization of ward default values and further refinement on an individual basis seems likely to improve usability. The data was presented during the ASA 2023 Annual Meeti","url":"https://finance.yahoo.com/news/ge-healthcare-announces-study-results-203000724.html"},{"category":"company","date":1697341080,"headline":"GE HealthCare announces new data from COSMOS Phase 1 study","id":123182817,"image":"","symbol":"GEHC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3161808051"},{"category":"company","date":1697115600,"headline":"GE HealthCare Signs $44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury and Enhance National Preparedness for Mass Casualty Incidents","id":123104662,"image":"https://media.zenfs.com/en/business-wire.com/7c61d5b6ed2278a26d62170cf690e6db","symbol":"GEHC","publisher":"Yahoo","summary":"CHICAGO, October 12, 2023--GE HealthCare (Nasdaq: GEHC) today announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA)—part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS)—to develop and obtain regulatory clearance for next-generation advanced point-of-care ultrasound technology with new artificial intelligence (AI) applications. Technology resulting from t","url":"https://finance.yahoo.com/news/ge-healthcare-signs-44-million-130000412.html"},{"category":"company","date":1697106720,"headline":"GE HealthCare enters $44M contract to build AI-augmented ultrasound technology","id":123120723,"image":"","symbol":"GEHC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3157414106"},{"category":"company","date":1697098320,"headline":"GE HealthCare in $44M deal with BARDA for AI applications to treat trauma","id":123120725,"image":"","symbol":"GEHC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3157233946"},{"category":"company","date":1697089920,"headline":"7 Top Tech Stocks To Get Behind for Q4","id":123109884,"image":"","symbol":"GEHC","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3157082889"},{"category":"company","date":1697076780,"headline":"GE Healthcare (NASDAQ:GEHC) Lands Deal to Make AI-Powered Ultrasound Tech","id":123120728,"image":"","symbol":"GEHC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3157718558"},{"category":"company","date":1697076600,"headline":"GE Healthcare (NASDAQ:GEHC) Announces Ambitious New Building Plans","id":123120729,"image":"","symbol":"GEHC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3157714758"},{"category":"company","date":1697074380,"headline":"GE Healthcare (NASDAQ:GEHC) Slips on Ambitious New Building Plans","id":123120730,"image":"","symbol":"GEHC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3157663014"},{"category":"company","date":1697025600,"headline":"SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers","id":123092839,"image":"https://media.zenfs.com/en/business-wire.com/bb05d6110e546b6c402976efa77abb2c","symbol":"GEHC","publisher":"Yahoo","summary":"CHALFONT ST GILES, England, October 11, 2023--SOFIE Biosciences and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers","url":"https://finance.yahoo.com/news/sofie-ge-healthcare-enter-licensing-120000837.html"},{"category":"company","date":1696998840,"headline":"Bentley Systems appoints Kristin Fallon as chief marketing officer","id":123084122,"image":"","symbol":"GEHC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3155294118"},{"category":"company","date":1696875824,"headline":"Corporate Spinoffs Are Surging: How Not To Get Taken For A Spin","id":123051082,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455953320/image_1455953320.jpg?io=getty-c-w1536","symbol":"GEHC","publisher":"SeekingAlpha","summary":"Investors in corporate spinoffs historically outperformed market by unlocking hidden value and taking advantage of investor constraints and biases. Read more here.","url":"https://seekingalpha.com/article/4639809-corporate-spinoffs-are-surging-how-not-to-get-taken-for-spin"},{"category":"company","date":1696863480,"headline":"GE HealthCare’s growing list of medical institutions conducting human subject research studies with its novel photon counting CTi technology further expands with the addition of Stanford Medicine","id":123047314,"image":"https://media.zenfs.com/en/business-wire.com/62b3ffafb522008e06014d603b115366","symbol":"GEHC","publisher":"Yahoo","summary":"WAUKESHA, Wis., October 09, 2023--As part of a research study, researchers at Stanford Medicine, Department of Radiology recently began scanning human subjects on GE HealthCare’s novel photon counting CT prototype designed with Deep Silicon detectors,i,ii which aims to greatly enhance imaging capabilities and provide clinicians the information and data they need to help enable improved patient outcomes across oncology, cardiology, neurology, and other clinical CT applications.","url":"https://finance.yahoo.com/news/ge-healthcare-growing-list-medical-145800308.html"},{"category":"company","date":1696855020,"headline":"10 Health Care Stocks Whale Activity In Today's Session","id":123045292,"image":"","symbol":"GEHC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3152409661"}]}